22 ME Rev Stat § 7262 (2021)
2021 Maine Revised Statutes|TITLE 22: HEALTH AND WELFARE|Subtitle 4: HUMAN SERVICES|Part 3: DRUG ABUSE|Chapter 1604: INTERSTATE PRESCRIPTION MONITORING PROGRAM COMPACT|22 §7262. Definitions - Article 2

 §7262. Definitions - Article 2 As used in this chapter, unless the context otherwise indicates, the following terms have the following meanings.   [PL 2011, c. 217, §1 (NEW).]1.  Authentication.  "Authentication" means the process of verifying the identity and credentials of a person before authorizing access to prescription data.   [PL 2011, c. 217, §1 (NEW).] 2.  Authorized.  "Authorized" means the granting of access privileges to prescription data.   [PL 2011, c. 217, §1 (NEW).] 3.  Bylaws.  "Bylaws" means those bylaws established by the interstate commission pursuant to section 7268 for its governance or for directing or controlling its actions and conduct.   [PL 2011, c. 217, §1 (NEW).] 4.  Commissioner.  "Commissioner" means the voting representative appointed by each member state pursuant to section 7266.   [PL 2011, c. 217, §1 (NEW).] 5.  Interstate commission or commission.  "Interstate commission" or "commission" means the Interstate Prescription Monitoring Program Commission created pursuant to section 7266.   [PL 2011, c. 217, §1 (NEW).] 6.  Member state.  "Member state" means any state that has adopted a prescription monitoring program and has enacted the enabling compact legislation.   [PL 2011, c. 217, §1 (NEW).] 7.  Practitioner.  "Practitioner" means a person licensed, registered or otherwise permitted to prescribe or dispense a prescription drug.   [PL 2011, c. 217, §1 (NEW).] 8.  Prescription data.  "Prescription data" means data transmitted by a prescription monitoring program that contains patient, prescriber, dispenser and prescription drug information.   [PL 2011, c. 217, §1 (NEW).] 9.  Prescription drug.  "Prescription drug" means any drug required to be reported to a state prescription monitoring program and includes but is not limited to substances listed in the federal Controlled Substances Act.   [PL 2011, c. 217, §1 (NEW).] 10.  Prescription monitoring program.  "Prescription monitoring program" means a program that collects, manages, analyzes and provides prescription data under the auspices of a state.   [PL 2011, c. 217, §1 (NEW).] 11.  Requestor.  "Requestor" means a person authorized by a member state who has initiated a request for prescription data.   [PL 2011, c. 217, §1 (NEW).] 12.  Rule.  "Rule" means a written statement by the interstate commission promulgated pursuant to section 7267 that is of general applicability; implements, interprets or prescribes a policy or provision of the compact; or is an organizational, procedural or practice requirement of the commission and has the force and effect of statutory law in a member state. "Rule" includes the amendment, repeal or suspension of an existing rule.   [PL 2011, c. 217, §1 (NEW).] 13.  State.  "State" means any state, commonwealth, district or territory of the United States.   [PL 2011, c. 217, §1 (NEW).] 14.  Technology infrastructure.  "Technology infrastructure" means the design, deployment and use of both individual technology-based components and the systems of such components to facilitate the transmission of information and prescription data among member states.   [PL 2011, c. 217, §1 (NEW).] 15.  Transmission.  "Transmission" means the release, transfer, provision or disclosure of information or prescription data among member states.   [PL 2011, c. 217, §1 (NEW).] SECTION HISTORY PL 2011, c. 217, §1 (NEW).